CLDN2 and peritonitis: In a study, IAP supplementation was found to reduce intestinal permeability and suppress gut bacterial translocation in the blood stream, liver, and lung in a mouse model of peritonitis, and also enhance transepithelial resistance and decrease claudin-2 expression in Caco-2 cells (Wang et al., 2015).